Logo image of NPCE

NEUROPACE INC (NPCE) Stock Fundamental Analysis

NASDAQ:NPCE - Nasdaq - US6412881053 - Common Stock - Currency: USD

10.91  -0.03 (-0.27%)

After market: 10.91 0 (0%)

Fundamental Rating

3

Overall NPCE gets a fundamental rating of 3 out of 10. We evaluated NPCE against 191 industry peers in the Health Care Equipment & Supplies industry. NPCE may be in some trouble as it scores bad on both profitability and health. NPCE shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year NPCE has reported negative net income.
NPCE had a negative operating cash flow in the past year.
NPCE had negative earnings in each of the past 5 years.
In the past 5 years NPCE always reported negative operating cash flow.
NPCE Yearly Net Income VS EBIT VS OCF VS FCFNPCE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -10M -20M -30M -40M

1.2 Ratios

NPCE's Return On Assets of -28.68% is in line compared to the rest of the industry. NPCE outperforms 45.03% of its industry peers.
Looking at the Return On Equity, with a value of -338.71%, NPCE is doing worse than 81.15% of the companies in the same industry.
Industry RankSector Rank
ROA -28.68%
ROE -338.71%
ROIC N/A
ROA(3y)-33.52%
ROA(5y)-34.1%
ROE(3y)-211.19%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NPCE Yearly ROA, ROE, ROICNPCE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 200 -200

1.3 Margins

The Gross Margin of NPCE (73.94%) is better than 83.77% of its industry peers.
NPCE's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for NPCE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 73.94%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y0.65%
NPCE Yearly Profit, Operating, Gross MarginsNPCE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 50 -50 -100

More info and screens

3

2. Health

2.1 Basic Checks

NPCE does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NPCE has more shares outstanding
The number of shares outstanding for NPCE has been increased compared to 5 years ago.
Compared to 1 year ago, NPCE has a worse debt to assets ratio.
NPCE Yearly Shares OutstandingNPCE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 10M 20M 30M
NPCE Yearly Total Debt VS Total AssetsNPCE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

NPCE has an Altman-Z score of -4.47. This is a bad value and indicates that NPCE is not financially healthy and even has some risk of bankruptcy.
NPCE's Altman-Z score of -4.47 is on the low side compared to the rest of the industry. NPCE is outperformed by 64.40% of its industry peers.
NPCE has a Debt/Equity ratio of 7.43. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 7.43, NPCE is doing worse than 87.96% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 7.43
Debt/FCF N/A
Altman-Z -4.47
ROIC/WACCN/A
WACC9.59%
NPCE Yearly LT Debt VS Equity VS FCFNPCE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

2.3 Liquidity

A Current Ratio of 5.37 indicates that NPCE has no problem at all paying its short term obligations.
NPCE has a better Current ratio (5.37) than 79.58% of its industry peers.
A Quick Ratio of 4.48 indicates that NPCE has no problem at all paying its short term obligations.
NPCE has a better Quick ratio (4.48) than 76.96% of its industry peers.
Industry RankSector Rank
Current Ratio 5.37
Quick Ratio 4.48
NPCE Yearly Current Assets VS Current LiabilitesNPCE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

7

3. Growth

3.1 Past

NPCE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.78%, which is quite impressive.
Looking at the last year, NPCE shows a very strong growth in Revenue. The Revenue has grown by 22.14%.
NPCE shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.67% yearly.
EPS 1Y (TTM)25.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.74%
Revenue 1Y (TTM)22.14%
Revenue growth 3Y20.93%
Revenue growth 5Y16.67%
Sales Q2Q%19.18%

3.2 Future

Based on estimates for the next years, NPCE will show a very strong growth in Earnings Per Share. The EPS will grow by 21.37% on average per year.
Based on estimates for the next years, NPCE will show a very strong growth in Revenue. The Revenue will grow by 22.01% on average per year.
EPS Next Y8.28%
EPS Next 2Y17.75%
EPS Next 3Y18.22%
EPS Next 5Y21.37%
Revenue Next Year17.66%
Revenue Next 2Y14.71%
Revenue Next 3Y18.37%
Revenue Next 5Y22.01%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NPCE Yearly Revenue VS EstimatesNPCE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M 200M 250M
NPCE Yearly EPS VS EstimatesNPCE Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -10 -20 -30

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NPCE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NPCE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NPCE Price Earnings VS Forward Price EarningsNPCE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NPCE Per share dataNPCE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

NPCE's earnings are expected to grow with 18.22% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.75%
EPS Next 3Y18.22%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NPCE!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEUROPACE INC

NASDAQ:NPCE (4/23/2025, 8:25:09 PM)

After market: 10.91 0 (0%)

10.91

-0.03 (-0.27%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-04 2025-03-04/amc
Earnings (Next)05-13 2025-05-13/amc
Inst Owners58.03%
Inst Owner Change0.03%
Ins Owners4.05%
Ins Owner Change-93.69%
Market Cap355.23M
Analysts84.62
Price Target17.51 (60.49%)
Short Float %1.04%
Short Ratio1.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)25.7%
Min EPS beat(2)20.82%
Max EPS beat(2)30.58%
EPS beat(4)4
Avg EPS beat(4)17.22%
Min EPS beat(4)2.47%
Max EPS beat(4)30.58%
EPS beat(8)8
Avg EPS beat(8)20.79%
EPS beat(12)10
Avg EPS beat(12)14.06%
EPS beat(16)10
Avg EPS beat(16)-704.47%
Revenue beat(2)1
Avg Revenue beat(2)3.81%
Min Revenue beat(2)-0.6%
Max Revenue beat(2)8.22%
Revenue beat(4)3
Avg Revenue beat(4)3.37%
Min Revenue beat(4)-0.6%
Max Revenue beat(4)8.22%
Revenue beat(8)7
Avg Revenue beat(8)9.09%
Revenue beat(12)10
Avg Revenue beat(12)6.52%
Revenue beat(16)12
Avg Revenue beat(16)5.17%
PT rev (1m)-2.3%
PT rev (3m)6.19%
EPS NQ rev (1m)0%
EPS NQ rev (3m)2.65%
EPS NY rev (1m)5.08%
EPS NY rev (3m)3.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.39%
Revenue NY rev (1m)0.72%
Revenue NY rev (3m)3.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 4.45
P/FCF N/A
P/OCF N/A
P/B 44.33
P/tB 44.33
EV/EBITDA N/A
EPS(TTM)-0.95
EYN/A
EPS(NY)-0.87
Fwd EYN/A
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)-0.55
OCFYN/A
SpS2.45
BVpS0.25
TBVpS0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -28.68%
ROE -338.71%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 73.94%
FCFM N/A
ROA(3y)-33.52%
ROA(5y)-34.1%
ROE(3y)-211.19%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.03%
GM growth 5Y0.65%
F-Score4
Asset Turnover0.84
Health
Industry RankSector Rank
Debt/Equity 7.43
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 17.3%
Cap/Sales 0.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.37
Quick Ratio 4.48
Altman-Z -4.47
F-Score4
WACC9.59%
ROIC/WACCN/A
Cap/Depr(3y)83.43%
Cap/Depr(5y)79.26%
Cap/Sales(3y)0.66%
Cap/Sales(5y)0.59%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.74%
EPS Next Y8.28%
EPS Next 2Y17.75%
EPS Next 3Y18.22%
EPS Next 5Y21.37%
Revenue 1Y (TTM)22.14%
Revenue growth 3Y20.93%
Revenue growth 5Y16.67%
Sales Q2Q%19.18%
Revenue Next Year17.66%
Revenue Next 2Y14.71%
Revenue Next 3Y18.37%
Revenue Next 5Y22.01%
EBIT growth 1Y20.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year32.73%
EBIT Next 3Y29.31%
EBIT Next 5YN/A
FCF growth 1Y8.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.89%
OCF growth 3YN/A
OCF growth 5YN/A